# Boston Scientific Corporation (BSX) — Q3-2019 Earnings Results

**Report date:** 2019-10-23 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2019

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Up 5.0%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.39 | N/A | +1.87% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on the company's ability to manage costs and drive profitability. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They highlighted ongoing investments in innovation as a key driver for future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report shows a solid performance with an EPS beat, which likely contributed to the stock's 5% increase. The positive reaction reflects investor confidence in the company's ongoing strategies, even without revenue details. The lack of guidance may leave some investors cautious, but the focus on innovation suggests a commitment to future growth.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2019_